查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970107

2026年全球癌症診斷人工智慧市場報告

Artificial Intelligence In Cancer Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧在癌症診斷領域的市場規模迅速擴張。預計該市場規模將從2025年的5.2億美元成長到2026年的6.9億美元，複合年成長率（CAGR）為31.3%。過去幾年的成長主要歸功於醫學影像數據的增加、電腦輔助診斷技術的早期應用、癌症發生率的上升、影像技術的進步以及醫療數位化進程的推進。

預計未來幾年，用於癌症診斷的人工智慧市場將快速成長，到2030年將達到20.2億美元，複合年成長率（CAGR）為30.9%。預測期內的成長要素包括：對早期癌症檢測的需求、精準醫療的普及、人工智慧提升診斷準確性、腫瘤學研究經費的增加以及基因組和影像數據的整合。預測期內的關鍵趨勢包括：人工智慧輔助的醫學影像分析、早期癌症檢測工具的普及、預測性腫瘤學分析的整合、診斷工作流程的自動化以及決策支援系統的廣泛應用。

預計未來幾年，癌症發生率的上升將推動人工智慧在癌症診斷領域的市場成長。癌症的特徵是細胞不受控制地增殖，會影響多個器官，並在全球範圍內造成顯著的發病率和死亡率。人工智慧正被應用於癌症診斷，以實現對醫學影像數據的準確高效分析，從而支持癌變病灶的早期發現和精確分類。例如，根據美國非營利組織美國癌症協會預測，截至2025年1月，美國預計將新增2,041,910例癌症病例，並有618,120例癌症相關死亡病例。此外，根據總部位於瑞士的政府間組織世界衛生組織（世衛組織）於2024年2月發布的報告，2022年全球約有2,000萬例新增癌症病例，造成970萬人死亡。據估計，約有5,350萬人能在確診癌症後的五年內存活。因此，癌症發生率的上升預計將推動人工智慧在癌症診斷領域的市場擴張。

在癌症診斷人工智慧市場，主要企業正致力於建立策略合作夥伴關係，以加速人工智慧驅動的數位病理技術在癌症診斷領域的部署。策略夥伴關係關係是指各組織整合自身優勢與資源，進而提升通用效益與成果。例如，2023年10月，瑞士診斷和製藥公司羅氏宣布與以色列醫療技術公司Ibex Medical Analytics以及美國雲端服務供應商亞馬遜網路服務（AWS）展開合作。這將使病理檢查室能夠利用Navify的數位病理軟體平台，並存取Ibex的人工智慧驅動的決策支援工具，以輔助診斷乳癌和攝護腺癌。 Ibex Medical Analytics與羅氏的合作將推動開發先進的人工智慧流程，幫助病理學家和檢查室最大限度地發揮數位轉型的優勢。羅氏和Ibex基於雲端的數位病理和人工智慧解決方案運作，為病理檢查室提供擴充性且永續性的平台。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球人工智慧在癌症診斷領域的市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因體學、精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 人工智慧輔助醫學影像分析
    • 癌症早期檢測工具的發展
    • 預測性腫瘤學分析的整合
    • 診斷工作流程自動化
    • 決策支援系統採用範圍擴大

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷中心
  • 醫學研究機構
  • 腫瘤診所
  • CRO（受託研究機構）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球人工智慧在癌症診斷領域的市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球人工智慧癌症診斷市場規模、對比及成長率分析
  • 全球人工智慧在癌症診斷領域的市場表現：規模與成長，2020-2025年
  • 全球人工智慧癌症診斷市場預測：規模與成長，2025-2030年及2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按組件
  • 軟體解決方案、硬體和服務
  • 癌症類型
  • 乳癌、肺癌、攝護腺癌、大腸癌、腦瘤和其他類型的癌症
  • 透過使用
  • 篩檢與診斷、腫瘤辨識、後續觀察、治療
  • 最終用戶
  • 醫院、醫學研究機構、診斷中心、合約研究機構
  • 按類型細分：軟體解決方案
  • 影像分析軟體、預測分析軟體、決策支援系統、資料管理平台
  • 按類型細分：硬體
  • 醫療影像設備、生物標記檢測設備、計算基礎設施
  • 按類型細分：服務
  • 諮詢服務、實施服務、維護及支援服務、訓練服務

第10章各國市場/產業指標

第11章 區域與國別分析

  • 全球癌症診斷人工智慧市場：按地區分類，實際結果和預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球人工智慧癌症診斷市場：按國家/地區分類，實際數據和預測數據（2020-2025 年、2025-2030 年預測、2035 年預測）。

第12章 亞太市場

第13章：中國市場

第14章：印度市場

第15章：日本市場

第16章：澳洲市場

第17章：印尼市場

第18章：韓國市場

第19章 台灣市場

第20章：東南亞市場

第21章 西歐市場

第22章英國市場

第23章：德國市場

第24章：法國市場

第25章：義大利市場

第26章：西班牙市場

第27章 東歐市場

第28章：俄羅斯市場

第29章 北美市場

第30章：美國市場

第31章：加拿大市場

第32章：南美洲市場

第33章：巴西市場

第34章 中東市場

第35章：非洲市場

第36章 市場監理與投資環境

第37章：競爭格局與公司概況

  • 人工智慧在癌症診斷領域的市場：競爭格局和市場佔有率（2024 年）
  • 人工智慧在癌症診斷領域的市場：公司估值矩陣
  • 人工智慧在癌症診斷領域的市場：公司概況
    • Microsoft Corporation
    • Siemens
    • Roche Holding AG
    • Google LCC
    • International Business Machines Corporation

第38章 其他大型企業和創新企業

  • Thermo Fisher Scientific Inc., Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision

第39章 全球市場競爭基準分析與儀錶板

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年人工智慧在癌症診斷領域的市場前景：提供新機會的國家
  • 2030年人工智慧在癌症診斷領域的市場前景：新興領域蘊藏新的機會
  • 2030年癌症診斷人工智慧市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: IT3MAICD01_G26Q1

Artificial intelligence (AI) in cancer diagnostics involves the application of advanced computational techniques and algorithms to aid in the detection, diagnosis, and characterization of cancer. This technology is employed to enhance the speed, accuracy, and efficiency of cancer imaging tests, achieving comparable accuracy to radiologists in detecting mammographic abnormalities.

The main components of artificial intelligence in cancer diagnostics include software solutions, hardware, and services. Software solutions are customized applications or systems designed to address specific business needs, and AI-powered software in cancer diagnostics utilizes machine learning algorithms and computer vision techniques to analyze medical images, genetic data, and clinical records. This enables accurate cancer detection, classification, and treatment prediction. These AI applications are utilized in various types of cancer such as breast cancer, lung cancer, prostate cancer, colorectal cancer, and brain tumors. They are applied in screening and diagnosis, tumor identification, surveillance, and treatment planning and are used by hospitals, medical research institutes, diagnostic centers, and contract research organizations.

Tariffs have impacted the AI in cancer diagnostics market by increasing costs for imported imaging devices, computing hardware, and specialized diagnostic equipment. These effects are most visible in hospital and diagnostic center deployments across north america and europe. Higher equipment costs have affected procurement timelines. However, tariffs are promoting regional manufacturing, local technology partnerships, and software driven diagnostic innovation.

The artificial intelligence in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in cancer diagnostics market statistics, including artificial intelligence in cancer diagnostics industry global market size, regional shares, competitors with a artificial intelligence in cancer diagnostics market share, detailed artificial intelligence in cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cancer diagnostics industry. This artificial intelligence in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.52 billion in 2025 to $0.69 billion in 2026 at a compound annual growth rate (CAGR) of 31.3%. The growth in the historic period can be attributed to growth of medical imaging data, early adoption of computer aided diagnosis, rising cancer prevalence, advancements in imaging technologies, increased healthcare digitization.

The artificial intelligence in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 30.9%. The growth in the forecast period can be attributed to demand for early cancer detection, precision medicine adoption, AI driven diagnostic accuracy improvement, expansion of oncology research funding, integration of genomics and imaging data. Major trends in the forecast period include AI assisted medical imaging analysis, growth of early cancer detection tools, integration of predictive oncology analytics, automation of diagnostic workflows, rising adoption of decision support systems.

The increasing incidence of cancer is anticipated to drive the growth of the artificial intelligence in cancer diagnostics market in the coming years. Cancer is characterised by the uncontrolled growth of cells that affects various organs and leads to substantial morbidity and mortality across the globe. Artificial intelligence is applied in cancer diagnostics to enable accurate and efficient analysis of medical imaging data, supporting the early detection and precise classification of cancerous lesions. For instance, in January 2025, according to the American Cancer Society, a US-based non-profit organisation, the United States is expected to register 2,041,910 new cancer cases and 618,120 cancer-related deaths in 2025. Additionally, in February 2024, the World Health Organisation, a Switzerland-based intergovernmental body, reported that in 2022, nearly 20 million new cancer cases were recorded worldwide, resulting in 9.7 million deaths. Around 53.5 million people were estimated to be alive within five years of receiving a cancer diagnosis. Thus, the growing prevalence of cancer is projected to stimulate the expansion of the artificial intelligence in cancer diagnostics market.

Major companies operating in the artificial intelligence in cancer diagnostics market are concentrating on strategic collaborations to accelerate the rollout of AI-powered digital pathology technologies for cancer diagnosis. Strategic partnerships involve organisations combining their strengths and resources to achieve shared advantages and improved outcomes. For example, in October 2023, F. Hoffmann-La Roche AG, a Switzerland-based diagnostics and pharmaceutical company, announced a collaboration with Ibex Medical Analytics, an Israel-based medical technology firm, and Amazon Web Services, Inc., a US-based cloud service provider, enabling pathology laboratories to use the navify Digital Pathology software platform to access Ibex's AI-driven decision-support tools for assisting physicians in diagnosing breast and prostate cancer. The partnership between Ibex Medical Analytics and Roche is enabling the development of advanced AI-powered processes that help pathologists and laboratories fully utilise digital transformation. The cloud-based digital pathology and artificial intelligence solutions from Roche and Ibex operate on Amazon Web Services (AWS), delivering a scalable and sustainable platform for pathology laboratories.

In July 2025, RadNet Inc., a US-based diagnostic imaging and digital health company, acquired iCAD Inc. for an undisclosed amount. Through this acquisition, RadNet seeks to enhance its cancer screening capabilities by incorporating iCAD's AI-driven breast health technologies for mammography detection, risk assessment, and workflow optimisation. iCAD Inc. is a US-based company that develops artificial intelligence solutions focused on breast cancer detection, risk analysis, and screening efficiency.

Major companies operating in the artificial intelligence in cancer diagnostics market are Microsoft Corporation; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI) in the cancer diagnostics market consists of revenues earned by entities by providing services such as data analysis, image recognition, personalized medicine, and decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the cancer diagnostics market also includes sales of AI-based diagnostic tools, predictive analytics tools, and a virtual tumor board. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Cancer Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software Solutions; Hardware; Services
  • 2) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Types
  • 3) By Application: Screening And Diagnosis; Tumor Identification; Surveillance; Treatment
  • 4) By End-User: Hospitals; Medical Research Institute; Diagnostic Centers; Contract Research Organization
  • Subsegments:
  • 1) By Software Solutions: Imaging Analysis Software; Predictive Analytics Software; Decision Support Systems; Data Management Platforms
  • 2) By Hardware: Imaging Devices; Biomarkers Detection Equipment; Computing Infrastructure
  • 3) By Services: Consulting Services; Implementation Services; Maintenance And Support Services; Training Services
  • Companies Mentioned: Microsoft Corporation; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence In Cancer Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Intelligence In Cancer Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence In Cancer Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Intelligence In Cancer Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 AI Assisted Medical Imaging Analysis
    • 4.2.2 Growth Of Early Cancer Detection Tools
    • 4.2.3 Integration Of Predictive Oncology Analytics
    • 4.2.4 Automation Of Diagnostic Workflows
    • 4.2.5 Rising Adoption Of Decision Support Systems

5. Artificial Intelligence In Cancer Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Medical Research Institutes
  • 5.4 Oncology Clinics
  • 5.5 Contract Research Organizations

6. Artificial Intelligence In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence In Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Intelligence In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Intelligence In Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Intelligence In Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Intelligence In Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence In Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence In Cancer Diagnostics Market Segmentation

  • 9.1. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software Solutions, Hardware, Services
  • 9.2. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
  • 9.3. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
  • 9.4. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization
  • 9.5. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms
  • 9.6. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure
  • 9.7. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Implementation Services, Maintenance And Support Services, Training Services

10. Artificial Intelligence In Cancer Diagnostics Market, Industry Metrics By Country

  • 10.1. Global Artificial Intelligence In Cancer Diagnostics Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global Artificial Intelligence In Cancer Diagnostics Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence In Cancer Diagnostics Market Regional And Country Analysis

  • 11.1. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market

  • 12.1. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence In Cancer Diagnostics Market

  • 13.1. China Artificial Intelligence In Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence In Cancer Diagnostics Market

  • 14.1. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence In Cancer Diagnostics Market

  • 15.1. Japan Artificial Intelligence In Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence In Cancer Diagnostics Market

  • 16.1. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence In Cancer Diagnostics Market

  • 17.1. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence In Cancer Diagnostics Market

  • 18.1. South Korea Artificial Intelligence In Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence In Cancer Diagnostics Market

  • 19.1. Taiwan Artificial Intelligence In Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence In Cancer Diagnostics Market

  • 20.1. South East Asia Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence In Cancer Diagnostics Market

  • 21.1. Western Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence In Cancer Diagnostics Market

  • 22.1. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence In Cancer Diagnostics Market

  • 23.1. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence In Cancer Diagnostics Market

  • 24.1. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence In Cancer Diagnostics Market

  • 25.1. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence In Cancer Diagnostics Market

  • 26.1. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market

  • 27.1. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence In Cancer Diagnostics Market

  • 28.1. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence In Cancer Diagnostics Market

  • 29.1. North America Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence In Cancer Diagnostics Market

  • 30.1. USA Artificial Intelligence In Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence In Cancer Diagnostics Market

  • 31.1. Canada Artificial Intelligence In Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence In Cancer Diagnostics Market

  • 32.1. South America Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence In Cancer Diagnostics Market

  • 33.1. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence In Cancer Diagnostics Market

  • 34.1. Middle East Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence In Cancer Diagnostics Market

  • 35.1. Africa Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence In Cancer Diagnostics Market Regulatory and Investment Landscape

37. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 37.1. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. Artificial Intelligence In Cancer Diagnostics Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. Artificial Intelligence In Cancer Diagnostics Market Company Profiles
    • 37.3.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.2. Siemens Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.4. Google LCC Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.5. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence In Cancer Diagnostics Market Other Major And Innovative Companies

  • Thermo Fisher Scientific Inc., Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision

39. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Artificial Intelligence In Cancer Diagnostics Market

41. Artificial Intelligence In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 41.1. Artificial Intelligence In Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 41.2. Artificial Intelligence In Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 41.3. Artificial Intelligence In Cancer Diagnostics Market In 2030 - Growth Strategies
    • 41.3.1. Market Trend Based Strategies
    • 41.3.2. Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer